Market Overview:
The global rapid cancer test kit market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, growing awareness about early detection of cancer, and technological advancements in rapid cancer test kits.
Based on type, the global rapid cancer test kit market is segmented into bladder cancer detection kit, prostate cancer detection kit, cervicalcancer detection kit, coloncancerdetectionkit and other types. The bladdercancerdetectionkit segment is expected to grow at a CAGR of 11% during the forecast period from 2018 to 2030. This growth can be attributedto the increasing incidenceof bladder cancers worldwide and technological advancements in urine-based tests for detecting bladder cancers. Based on application,theglobalrapidcancertestkitmarketissegmentedinto hospital applications, home applications and other applications. The hospitalapplicationsegmentisexpectedtogrowatacagrof10%duringtheforecastperiodfrom2018to2030due tobethegrowing demand for early diagnosisand treatment of various types of cancersin hospitals across the globe.
Product Definition:
A rapid cancer test kit is a diagnostic tool used to detect the presence of cancer in a patient. The importance of such a kit is that it can provide results in a relatively short amount of time, which can be important for patients who are anxious about their diagnosis.
Bladder Cancer Detection Kit:
The global Bladder Cancer Detection Kit, it's usage and growth factor in the market for Rapid Cancer Test Kit is expected to witness significant growth over the forecast period. The major drivers of this market are growing prevalence rate of bladder cancer coupled with increasing demand for early diagnosis. According to American Cancer Society, Inc., bladder cancer is one of the least common cancers in men above 40 years but accounts for more than 10% of all new cancers in women below 60 years every year.
Prostate Cancer Detection Kit:
The prostate cancer detection kit is used for detecting the level of a specific protein called Prostate-specific Antigen (PSA) in the blood. The test helps to diagnose aggressive forms of prostate cancer that has already spread to other parts of the body.
Application Insights:
The other application segment includes blood cancer detection kits, skin cancer detection kits, and endometrial cancer detection kit. The other applications include private settings such as homes and hospitals. In 2017, the hospital application dominated the market with a revenue share of over 80%. This is due to factors such as availability of advanced diagnostic equipment in hospitals coupled with rising prevalence of various cancers across the globe.
Rapid testing for bladder cancer has led to an upsurge in adoption at home settings owing to its convenience compared to conventional testing methods such as dipstick tests or microscopy which require several hours before results are obtained. Conventional tests also have limitations since they cannot detect early stage bladder tumors which may only cause mild symptoms at later stages when it has spread beyond the kidneys; this leads to under-diagnosis and subsequently delays treatment procedures resulting in increased mortality rates among patients suffering from Bladder Cancer (T1 & T2).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, continuous research & development activities, and high adoption rate for advanced cancer detection techniques. The Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government initiatives and rising awareness about early diagnosis among people. Moreover, an increase in disposable income levels will boost demand for rapid diagnostic tests in this region as they are affordable by most patients & users.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is primarily due to the aging population and the increase in lifestyle-related cancers. According to the World Health Organization, there were 14 million new cases of cancer in 2012, and this number is expected to rise to 21 million by 2030. This presents a huge opportunity for rapid cancer test kits manufacturers as they can help healthcare providers diagnose and treat patients more quickly.
- Advances in technology: Rapid cancer test kits are becoming increasingly sophisticated as technology advances. They are now able to detect a wider range of biomarkers, making them more accurate than ever before. This means that they can be used not only for early diagnosis but also for monitoring the progress of treatment and detecting recurrence or metastasis.
- Growing demand from emerging markets: The demand for rapid cancer test kits is growing rapidly in emerging markets such as China and India due to the increasing prevalence ofcancerandthe rising awareness about early detection techniques among consumers there.. These markets offer tremendous potential growth opportunities for manufacturers of these products .
Scope Of The Report
Report Attributes
Report Details
Report Title
Rapid Cancer Test Kit Market Research Report
By Type
Bladder Cancer Detection Kit, Prostate Cancer Detection Kit, Cervical Cancer Detection Kit, Colon Cancer Detection Kit, Other
By Application
Hospital, Home, Other
By Companies
Xiamen Biotime Biotechnology, Abingdon Health, Ulti Med Products, Alere, Hologic, Diagnosis, BIOMERICA, Exact Sciences, IDL Biotech, Firstep Bioresearch
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Rapid Cancer Test Kit Market Report Segments:
The global Rapid Cancer Test Kit market is segmented on the basis of:
Types
Bladder Cancer Detection Kit, Prostate Cancer Detection Kit, Cervical Cancer Detection Kit, Colon Cancer Detection Kit, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Home, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Xiamen Biotime Biotechnology
- Abingdon Health
- Ulti Med Products
- Alere
- Hologic
- Diagnosis
- BIOMERICA
- Exact Sciences
- IDL Biotech
- Firstep Bioresearch
Highlights of The Rapid Cancer Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bladder Cancer Detection Kit
- Prostate Cancer Detection Kit
- Cervical Cancer Detection Kit
- Colon Cancer Detection Kit
- Other
- By Application:
- Hospital
- Home
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rapid Cancer Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rapid cancer test kit is a diagnostic tool used to detect the presence of cancer cells in a sample.
Some of the major players in the rapid cancer test kit market are Xiamen Biotime Biotechnology, Abingdon Health, Ulti Med Products, Alere, Hologic, Diagnosis, BIOMERICA, Exact Sciences, IDL Biotech, Firstep Bioresearch.
The rapid cancer test kit market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rapid Cancer Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rapid Cancer Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rapid Cancer Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rapid Cancer Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rapid Cancer Test Kit Market Size & Forecast, 2020-2028
4.5.1 Rapid Cancer Test Kit Market Size and Y-o-Y Growth
4.5.2 Rapid Cancer Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bladder Cancer Detection Kit
5.2.2 Prostate Cancer Detection Kit
5.2.3 Cervical Cancer Detection Kit
5.2.4 Colon Cancer Detection Kit
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Home
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rapid Cancer Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rapid Cancer Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bladder Cancer Detection Kit
9.6.2 Prostate Cancer Detection Kit
9.6.3 Cervical Cancer Detection Kit
9.6.4 Colon Cancer Detection Kit
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Home
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bladder Cancer Detection Kit
10.6.2 Prostate Cancer Detection Kit
10.6.3 Cervical Cancer Detection Kit
10.6.4 Colon Cancer Detection Kit
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Home
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bladder Cancer Detection Kit
11.6.2 Prostate Cancer Detection Kit
11.6.3 Cervical Cancer Detection Kit
11.6.4 Colon Cancer Detection Kit
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Home
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bladder Cancer Detection Kit
12.6.2 Prostate Cancer Detection Kit
12.6.3 Cervical Cancer Detection Kit
12.6.4 Colon Cancer Detection Kit
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Home
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bladder Cancer Detection Kit
13.6.2 Prostate Cancer Detection Kit
13.6.3 Cervical Cancer Detection Kit
13.6.4 Colon Cancer Detection Kit
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Home
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rapid Cancer Test Kit Market: Competitive Dashboard
14.2 Global Rapid Cancer Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Xiamen Biotime Biotechnology
14.3.2 Abingdon Health
14.3.3 Ulti Med Products
14.3.4 Alere
14.3.5 Hologic
14.3.6 Diagnosis
14.3.7 BIOMERICA
14.3.8 Exact Sciences
14.3.9 IDL Biotech
14.3.10 Firstep Bioresearch
